Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
MDA Space Ltd. is a renowned leader in the high-technology aerospace industry, specializing in providing advanced solutions for geospatial data, satellite systems, and robotics. The company's primary function is to develop and deliver sophisticated space and defense technologies, which have applications in observation, communication, and exploration. MDA plays a crucial role in supporting vital sectors such as defense, weather, mapping, and maritime operations, helping governments and commercial enterprises enhance their capabilities through space technology. MDA Space Ltd. is known for its cutting-edge radar satellites and expertise in robotics used in space missions, like the Canadarm on space shuttles. Its prowess in providing satellite communication systems facilitates vital connections across continents and oceans, while geospatial imagery aids in resource management, environmental monitoring, and infrastructure planning. As a major player in space and defense technology, MDA contributes significantly to global innovation, enhancing satellite capabilities and supporting international space missions. Its advancements have far-reaching impacts, shaping the future of satellite technology and contributing to national security and scientific discovery.
C$51.18
C$2.49 (-4.64%)
EOD Jun 25, 2026 · Twelve Data
Operating margin is thin at 9.66%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 51.2%, still solid. Free cash flow declined 79% despite revenue growth, conversion is weakening.
At 64x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Free cash flow declined 79% versus the prior year, cash generation momentum has weakened.
64.1x earnings. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
C$1.75B
▲ +51.2% YoY
Net Income (TTM)
C$105M
▲ +36.6% YoY
Op. Margin
9.31%
▼ -0.2pp YoY
ROIC
7.30%
▲ +2.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-C$101M
▼ -78.5% YoY
Op. Cash Flow (TTM)
C$180M
▼ -59.8% YoY
Net Debt
C$259M
Cash & Equiv.
C$152M
3Y CAGR: +36.6%
Continue Research
At a P/E of 64.1, MDA Space (MDA)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, MDA Space scores 19/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
MDA Space scores 19 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 9.3% operating margin and a 7.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh MDA's valuation and scores 19/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.